Optimization of rhabdomyosarcoma disseminated disease assessment by flow cytometry.

Abstract

Rhabdomyosarcoma (RMS) is the most common type of soft tissue sarcoma in children. Circulating tumor cells in peripheral blood or disseminated to bone marrow, a concept commonly referred to as minimal residual disease (MRD), are thought to be key to the prediction of metastasis and treatment efficacy. To date, two MRD markers, MYOD and MYOGENIN, have been… (More)
DOI: 10.1002/cyto.a.22514

Topics

5 Figures and Tables

Cite this paper

@article{AlmaznMoga2014OptimizationOR, title={Optimization of rhabdomyosarcoma disseminated disease assessment by flow cytometry.}, author={Ana Almaz{\'a}n-Moga and Josep Roma and Carla Molist and I. Vidal and Luz Jubierre and Aroa Soriano and Miguel F Segura and Anna Llort and Josep S{\'a}nchez de Toledo and Soledad Gallego}, journal={Cytometry. Part A : the journal of the International Society for Analytical Cytology}, year={2014}, volume={85 12}, pages={1020-9} }